5545f05eee
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
142 KiB
142 KiB
| 1 | Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies. | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | Subject | Subject Data Revision | Screen No. | Age | Age Unit | Gender | Visit | Visit Data Revision | Collected Time | Accession | Test Group | Test | Administrative Question | Value | Result Data Revision | Flags | Cancellation Reason | Comments | Range | Units |
| 3 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.1 | 0 - 5 | mg/L | ||||||||
| 4 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CELLULAR ELEMENTS | Ur RBC/HPF | 5 | 0 - 8 | /HPF | ||||||||
| 5 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CELLULAR ELEMENTS | Ur WBC/HPF | 1 | 0 - 12 | /HPF | ||||||||
| 6 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Total Bilirubin | 6 | 3 - 21 | umol/L | ||||||||
| 7 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.5 | 0 - 6.2 | umol/L | ||||||||
| 8 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Alkaline Phosphatase | 56 | 35 - 104 | U/L | ||||||||
| 9 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | ALT (SGPT) | 13 | 4 - 43 | U/L | ||||||||
| 10 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | AST (SGOT) | 18 | 8 - 40 | U/L | ||||||||
| 11 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | GGT | 22 | 5 - 50 | U/L | ||||||||
| 12 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | LDH | 162 | 53 - 234 | U/L | ||||||||
| 13 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Urea Nitrogen | 3.9 | 1.4 - 8.6 | mmol/L | ||||||||
| 14 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 71 | 31 - 101 | umol/L | ||||||||
| 15 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Glucose Fasting | 4.0 | 3.9 - 5.6 | mmol/L | ||||||||
| 16 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Serum Uric Acid | 242 | 149 - 446 | umol/L | ||||||||
| 17 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Calcium (EDTA) | 2.39 | 2.07 - 2.64 | mmol/L | ||||||||
| 18 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Phosphorus | 1.08 | 0.71 - 1.65 | mmol/L | ||||||||
| 19 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Total Protein | 64 | 60 - 80 | g/L | ||||||||
| 20 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Albumin-BCG | 44 | 33 - 49 | g/L | ||||||||
| 21 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Creatine Kinase | 52 | 26 - 192 | U/L | ||||||||
| 22 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Serum Sodium | 139 | 135 - 145 | mmol/L | ||||||||
| 23 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Serum Potassium | 4.3 | 3.5 - 5.2 | mmol/L | ||||||||
| 24 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Serum Bicarbonate | 22.9 | 19.3 - 29.3 | mmol/L | ||||||||
| 25 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||
| 26 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 119 | Result verified by repeat analysis | 115 - 158 | g/L | |||||||
| 27 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.36 | 0.34 - 0.48 | |||||||||
| 28 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 3.8 | L | Result verified by repeat analysis | 3.9 - 5.5 | TI/L | ||||||
| 29 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 30 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 96 | 80 - 100 | fL | ||||||||
| 31 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.80 | Result verified by repeat analysis | 3.8 - 10.7 | GI/L | |||||||
| 32 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.34 | Result verified by repeat analysis | 1.96 - 7.23 | GI/L | |||||||
| 33 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.86 | 0.8 - 3 | GI/L | ||||||||
| 34 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.44 | Result verified by repeat analysis | 0.12 - 0.92 | GI/L | |||||||
| 35 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.12 | Result verified by repeat analysis | 0 - 0.57 | GI/L | |||||||
| 36 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | Result verified by repeat analysis | 0 - 0.2 | GI/L | |||||||
| 37 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 63.8 | Result verified by repeat analysis | 40.5 - 75 | % | |||||||
| 38 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 27.3 | Result verified by repeat analysis | 15.4 - 48.5 | % | |||||||
| 39 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.5 | Result verified by repeat analysis | 2.6 - 10.1 | % | |||||||
| 40 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.8 | Result verified by repeat analysis | 0 - 6.8 | % | |||||||
| 41 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.5 | Result verified by repeat analysis | 0 - 2 | % | |||||||
| 42 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 459 | H | Result verified by repeat analysis | 130 - 394 | GI/L | ||||||
| 43 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 25.80 | H | 1.9 - 23 | uIU/mL | |||||||
| 44 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 45 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | LIPID PANEL | Direct HDL-C 4th Generation | 0.97 | L | 1.03 - 1.53 | mmol/L | |||||||
| 46 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | LIPID PANEL | Triglycerides (GPO) | 1.49 | 0.63 - 2.71 | mmol/L | ||||||||
| 47 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | LIPID PANEL | Cholesterol (High Performance) | 4.00 | L | 4.86 - 8.28 | mmol/L | |||||||
| 48 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | LIPID PANEL | LDL Chol Friedewald 4th | 2.35 | 0 - 3.34 | mmol/L | ||||||||
| 49 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | MICROORGANISMS | Ur Bacteria | Present | Ref Rng:Not present | |||||||||
| 50 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | RETICULOCYTES | Reticulocyte Count % | 0.9 | 0.6 - 2.5 | % | ||||||||
| 51 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | URINE MACRO PANEL | Ur Specific Gravity | 1.013 | 1.01 - 1.03 | |||||||||
| 52 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 53 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 54 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 55 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 56 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 57 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 58 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 59 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 60 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | URINE MACRO PANEL | Ur Leukocyte Esterase | Trace | H | Ref Rng:Negative | ||||||||
| 61 | CZ100120005 | 65 | years | Female | Part 2 OL Induction Day 29 | Apr 23, 2026 4:00 PM | 6226560887 | URINE MICRO PANEL | Ur Microscopic | Positive | NEGATIVE$ | NEGATIVE | ||||||||
| 62 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | C-REACTIVE PROTEIN | C Reactive Protein HS | <0.2 | Result verified by repeat analysis | 0 - 5 | mg/L | |||||||
| 63 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | ||||||||
| 64 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.0 | 0 - 6.2 | umol/L | ||||||||
| 65 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Alkaline Phosphatase | 60 | 40 - 129 | U/L | ||||||||
| 66 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | ALT (SGPT) | 35 | 5 - 48 | U/L | ||||||||
| 67 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | AST (SGOT) | 28 | 8 - 40 | U/L | ||||||||
| 68 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | GGT | 14 | 10 - 61 | U/L | ||||||||
| 69 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | LDH | 149 | 53 - 234 | U/L | ||||||||
| 70 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Urea Nitrogen | 4.0 | 1.4 - 8.6 | mmol/L | ||||||||
| 71 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 77 | 40 - 110 | umol/L | ||||||||
| 72 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Glucose Fasting | 4.7 | 3.9 - 5.6 | mmol/L | ||||||||
| 73 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Serum Uric Acid | 285 | 125 - 488 | umol/L | ||||||||
| 74 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Calcium (EDTA) | 2.41 | 2.07 - 2.64 | mmol/L | ||||||||
| 75 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Phosphorus | 1.11 | 0.71 - 1.65 | mmol/L | ||||||||
| 76 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Total Protein | 67 | 61 - 84 | g/L | ||||||||
| 77 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Albumin-BCG | 48 | 33 - 49 | g/L | ||||||||
| 78 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Creatine Kinase | 157 | 39 - 308 | U/L | ||||||||
| 79 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 80 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Serum Potassium | 3.9 | 3.5 - 5.2 | mmol/L | ||||||||
| 81 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Serum Bicarbonate | 24.5 | 19.3 - 29.3 | mmol/L | ||||||||
| 82 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||
| 83 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 154 | 127 - 181 | g/L | ||||||||
| 84 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.44 | 0.39 - 0.54 | |||||||||
| 85 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.0 | 4.5 - 6.4 | TI/L | ||||||||
| 86 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 87 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 88 | 79 - 96 | fL | ||||||||
| 88 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.52 | 3.8 - 10.7 | GI/L | ||||||||
| 89 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.31 | 1.96 - 7.23 | GI/L | ||||||||
| 90 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.76 | 0.91 - 4.28 | GI/L | ||||||||
| 91 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.32 | 0.12 - 0.92 | GI/L | ||||||||
| 92 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.12 | 0 - 0.57 | GI/L | ||||||||
| 93 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.01 | 0 - 0.2 | GI/L | ||||||||
| 94 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 59.8 | 40.5 - 75 | % | ||||||||
| 95 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 31.9 | 15.4 - 48.5 | % | ||||||||
| 96 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.8 | 2.6 - 10.1 | % | ||||||||
| 97 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.2 | 0 - 6.8 | % | ||||||||
| 98 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.3 | 0 - 2 | % | ||||||||
| 99 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 174 | 140 - 400 | GI/L | ||||||||
| 100 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 2.95 | 1.9 - 23 | uIU/mL | ||||||||
| 101 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 102 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | LIPID PANEL | Direct HDL-C 4th Generation | 1.39 | Result verified by repeat analysis | 1.03 - 1.53 | mmol/L | |||||||
| 103 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | LIPID PANEL | Triglycerides (GPO) | 0.75 | 0.5 - 2.81 | mmol/L | ||||||||
| 104 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | LIPID PANEL | Cholesterol (High Performance) | 3.90 | 3.31 - 6.1 | mmol/L | ||||||||
| 105 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | LIPID PANEL | LDL Chol Friedewald 4th | 2.17 | 0 - 3.34 | mmol/L | ||||||||
| 106 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | RETICULOCYTES | Reticulocyte Count % | 1.4 | 0.6 - 2.5 | % | ||||||||
| 107 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | URINE MACRO PANEL | Ur Specific Gravity | 1.012 | 1 - 1.04 | |||||||||
| 108 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | URINE MACRO PANEL | Ur pH | 6.5 | 5 - 8 | |||||||||
| 109 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 110 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 111 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 112 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 113 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 114 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 115 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 116 | CZ100120006 | 27 | years | Male | Part 2 OL Induction Day 29 | Apr 22, 2026 3:30 PM | 6226752554 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 117 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.5 | 0 - 5 | mg/L | |||||||
| 118 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Total Bilirubin | 8 | 3 - 21 | umol/L | |||||||
| 119 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.8 | 0 - 6.2 | umol/L | |||||||
| 120 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Alkaline Phosphatase | 54 | 35 - 104 | U/L | |||||||
| 121 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | ALT (SGPT) | 14 | 4 - 43 | U/L | |||||||
| 122 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | AST (SGOT) | 20 | 8 - 40 | U/L | |||||||
| 123 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | GGT | 23 | 5 - 50 | U/L | |||||||
| 124 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | LDH | 143 | 53 - 234 | U/L | |||||||
| 125 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Urea Nitrogen | 3.8 | 1.4 - 8.6 | mmol/L | |||||||
| 126 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 72 | 31 - 101 | umol/L | |||||||
| 127 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Glucose Fasting | 5.3 | 3.9 - 5.6 | mmol/L | |||||||
| 128 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Serum Uric Acid | 259 | 149 - 446 | umol/L | |||||||
| 129 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Calcium (EDTA) | 2.47 | 2.07 - 2.64 | mmol/L | |||||||
| 130 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Phosphorus | 1.20 | 0.71 - 1.65 | mmol/L | |||||||
| 131 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Total Protein | 69 | 60 - 80 | g/L | |||||||
| 132 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | |||||||
| 133 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Creatine Kinase | 41 | 26 - 192 | U/L | |||||||
| 134 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Serum Sodium | 143 | 135 - 145 | mmol/L | |||||||
| 135 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Serum Potassium | 4.7 | 3.5 - 5.2 | mmol/L | |||||||
| 136 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Serum Bicarbonate | 25.2 | 19.3 - 29.3 | mmol/L | |||||||
| 137 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | |||||||
| 138 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 122 | 115 - 158 | g/L | |||||||
| 139 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.37 | 0.34 - 0.48 | ||||||||
| 140 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.0 | 3.9 - 5.5 | TI/L | |||||||
| 141 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | ||||||||
| 142 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 94 | 80 - 100 | fL | |||||||
| 143 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 7.11 | 3.8 - 10.7 | GI/L | |||||||
| 144 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.82 | 1.96 - 7.23 | GI/L | |||||||
| 145 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.76 | 0.8 - 3 | GI/L | |||||||
| 146 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.43 | 0.12 - 0.92 | GI/L | |||||||
| 147 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.07 | 0 - 0.57 | GI/L | |||||||
| 148 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.02 | 0 - 0.2 | GI/L | |||||||
| 149 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 67.8 | 40.5 - 75 | % | |||||||
| 150 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 24.8 | 15.4 - 48.5 | % | |||||||
| 151 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.1 | 2.6 - 10.1 | % | |||||||
| 152 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.0 | 0 - 6.8 | % | |||||||
| 153 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.2 | 0 - 2 | % | |||||||
| 154 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 466 | R | H | 130 - 394 | GI/L | |||||
| 155 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.4 | <6.5 % | ||||||||
| 156 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 9.83 | 1.9 - 23 | uIU/mL | |||||||
| 157 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | ||||||||
| 158 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | LIPID PANEL | Direct HDL-C 4th Generation | 1.06 | 1.03 - 1.53 | mmol/L | |||||||
| 159 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | LIPID PANEL | Triglycerides (GPO) | 1.56 | 0.63 - 2.71 | mmol/L | |||||||
| 160 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | LIPID PANEL | Cholesterol (High Performance) | 4.33 | L | 4.86 - 8.28 | mmol/L | ||||||
| 161 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | LIPID PANEL | LDL Chol Friedewald 4th | 2.56 | 0 - 3.34 | mmol/L | |||||||
| 162 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | RETICULOCYTES | Reticulocyte Count % | 1.1 | 0.6 - 2.5 | % | |||||||
| 163 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | TSH | TSH 3rd IS-QT | 0.806 | 0.45 - 5.33 | mIU/L | |||||||
| 164 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | URINE MACRO PANEL | Ur Specific Gravity | 1.010 | 1.01 - 1.03 | ||||||||
| 165 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | URINE MACRO PANEL | Ur pH | 6.0 | 5 - 8 | ||||||||
| 166 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | ||||||||
| 167 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | ||||||||
| 168 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | ||||||||
| 169 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | ||||||||
| 170 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | ||||||||
| 171 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | ||||||||
| 172 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | ||||||||
| 173 | CZ100120005 | 65 | years | Female | End of Phase/Treatment | R | Mar 25, 2026 5:00 PM | 6226560888 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | ||||||||
| 174 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | C-REACTIVE PROTEIN | C Reactive Protein HS | 0.2 | Result verified by repeat analysis | 0 - 5 | mg/L | ||||||
| 175 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Total Bilirubin | 6 | 3 - 21 | umol/L | |||||||
| 176 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.3 | 0 - 6.2 | umol/L | |||||||
| 177 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Alkaline Phosphatase | 62 | 40 - 129 | U/L | |||||||
| 178 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | ALT (SGPT) | 39 | 5 - 48 | U/L | |||||||
| 179 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | AST (SGOT) | 29 | 8 - 40 | U/L | |||||||
| 180 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | GGT | 13 | 10 - 61 | U/L | |||||||
| 181 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | LDH | 156 | 53 - 234 | U/L | |||||||
| 182 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Urea Nitrogen | 5.0 | 1.4 - 8.6 | mmol/L | |||||||
| 183 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 74 | 40 - 110 | umol/L | |||||||
| 184 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Glucose Fasting | 5.5 | 3.9 - 5.6 | mmol/L | |||||||
| 185 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Serum Uric Acid | 330 | 125 - 488 | umol/L | |||||||
| 186 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Calcium (EDTA) | 2.29 | 2.07 - 2.64 | mmol/L | |||||||
| 187 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Phosphorus | 1.11 | 0.71 - 1.65 | mmol/L | |||||||
| 188 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Total Protein | 66 | 61 - 84 | g/L | |||||||
| 189 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | |||||||
| 190 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Creatine Kinase | 149 | 39 - 308 | U/L | |||||||
| 191 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | |||||||
| 192 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Serum Potassium | 4.1 | 3.5 - 5.2 | mmol/L | |||||||
| 193 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Serum Bicarbonate | 23.2 | 19.3 - 29.3 | mmol/L | |||||||
| 194 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | |||||||
| 195 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 159 | 127 - 181 | g/L | |||||||
| 196 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.45 | 0.39 - 0.54 | ||||||||
| 197 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.1 | 4.5 - 6.4 | TI/L | |||||||
| 198 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | ||||||||
| 199 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 87 | 79 - 96 | fL | |||||||
| 200 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.94 | 3.8 - 10.7 | GI/L | |||||||
| 201 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.55 | 1.96 - 7.23 | GI/L | |||||||
| 202 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.81 | 0.91 - 4.28 | GI/L | |||||||
| 203 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.40 | 0.12 - 0.92 | GI/L | |||||||
| 204 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.15 | 0 - 0.57 | GI/L | |||||||
| 205 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | 0 - 0.2 | GI/L | |||||||
| 206 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 59.8 | 40.5 - 75 | % | |||||||
| 207 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 30.5 | 15.4 - 48.5 | % | |||||||
| 208 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.7 | 2.6 - 10.1 | % | |||||||
| 209 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.5 | 0 - 6.8 | % | |||||||
| 210 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.5 | 0 - 2 | % | |||||||
| 211 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 189 | 140 - 400 | GI/L | |||||||
| 212 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.1 | <6.5 % | ||||||||
| 213 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 19.10 | 1.9 - 23 | uIU/mL | |||||||
| 214 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | ||||||||
| 215 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | LIPID PANEL | Direct HDL-C 4th Generation | 1.09 | 1.03 - 1.53 | mmol/L | |||||||
| 216 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | LIPID PANEL | Triglycerides (GPO) | 1.96 | 0.5 - 2.81 | mmol/L | |||||||
| 217 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | LIPID PANEL | Cholesterol (High Performance) | 3.72 | 3.31 - 6.1 | mmol/L | |||||||
| 218 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | LIPID PANEL | LDL Chol Friedewald 4th | 1.73 | 0 - 3.34 | mmol/L | |||||||
| 219 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | RETICULOCYTES | Reticulocyte Count % | 1.2 | 0.6 - 2.5 | % | |||||||
| 220 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | TSH | TSH 3rd IS-QT | 1.089 | 0.45 - 5.33 | mIU/L | |||||||
| 221 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | URINE MACRO PANEL | Ur Specific Gravity | 1.019 | 1 - 1.04 | ||||||||
| 222 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | ||||||||
| 223 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | ||||||||
| 224 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | ||||||||
| 225 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | ||||||||
| 226 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | ||||||||
| 227 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | ||||||||
| 228 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | ||||||||
| 229 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | ||||||||
| 230 | CZ100120006 | 27 | years | Male | End of Phase/Treatment | R | Mar 25, 2026 3:00 PM | 6226752555 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | ||||||||
| 231 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | C-REACTIVE PROTEIN | C Reactive Protein HS | 9.2 | H | 0 - 5 | mg/L | |||||||
| 232 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Total Bilirubin | 16 | 3 - 21 | umol/L | ||||||||
| 233 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 4.6 | 0 - 6.2 | umol/L | ||||||||
| 234 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Alkaline Phosphatase | 77 | 40 - 129 | U/L | ||||||||
| 235 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | ALT (SGPT) | 37 | 5 - 48 | U/L | ||||||||
| 236 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | AST (SGOT) | 29 | 8 - 40 | U/L | ||||||||
| 237 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | GGT | 79 | R | H | 10 - 61 | U/L | ||||||
| 238 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | LDH | 103 | 53 - 234 | U/L | ||||||||
| 239 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Urea Nitrogen | 2.3 | 1.4 - 8.6 | mmol/L | ||||||||
| 240 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 74 | 40 - 110 | umol/L | ||||||||
| 241 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Glucose Fasting | 5.2 | 3.9 - 5.6 | mmol/L | ||||||||
| 242 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Serum Uric Acid | 427 | 125 - 488 | umol/L | ||||||||
| 243 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Calcium (EDTA) | 2.40 | 2.07 - 2.64 | mmol/L | ||||||||
| 244 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Phosphorus | 0.97 | 0.71 - 1.65 | mmol/L | ||||||||
| 245 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Total Protein | 71 | 61 - 84 | g/L | ||||||||
| 246 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||
| 247 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Creatine Kinase | 102 | 39 - 308 | U/L | ||||||||
| 248 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Serum Sodium | 138 | 132 - 147 | mmol/L | ||||||||
| 249 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Serum Potassium | 3.8 | 3.5 - 5.2 | mmol/L | ||||||||
| 250 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Serum Bicarbonate | 25.2 | 19.3 - 29.3 | mmol/L | ||||||||
| 251 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | CHEMISTRY PANEL | Serum Chloride | 97 | 94 - 112 | mmol/L | ||||||||
| 252 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 160 | 127 - 181 | g/L | ||||||||
| 253 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.45 | 0.39 - 0.54 | |||||||||
| 254 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.2 | 4.5 - 6.4 | TI/L | ||||||||
| 255 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 256 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 87 | 79 - 96 | fL | ||||||||
| 257 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 7.04 | 3.8 - 10.7 | GI/L | ||||||||
| 258 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.60 | 1.96 - 7.23 | GI/L | ||||||||
| 259 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.86 | 0.91 - 4.28 | GI/L | ||||||||
| 260 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.41 | 0.12 - 0.92 | GI/L | ||||||||
| 261 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.12 | 0 - 0.57 | GI/L | ||||||||
| 262 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||
| 263 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 65.3 | 40.5 - 75 | % | ||||||||
| 264 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 26.4 | 15.4 - 48.5 | % | ||||||||
| 265 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.8 | 2.6 - 10.1 | % | ||||||||
| 266 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.7 | 0 - 6.8 | % | ||||||||
| 267 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.7 | 0 - 2 | % | ||||||||
| 268 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 366 | 140 - 400 | GI/L | ||||||||
| 269 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.7 | <6.5 % | |||||||||
| 270 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | R | Mar 6, 2026 2:00 PM | 6226560891 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 16.55 | 1.9 - 23 | uIU/mL | |||||||
| 271 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 272 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | LIPID PANEL | Direct HDL-C 4th Generation | 1.23 | 1.03 - 1.53 | mmol/L | ||||||||
| 273 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | LIPID PANEL | Triglycerides (GPO) | 1.94 | 0.56 - 3.62 | mmol/L | ||||||||
| 274 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | LIPID PANEL | Cholesterol (High Performance) | 4.72 | 3.88 - 6.83 | mmol/L | ||||||||
| 275 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | LIPID PANEL | LDL Chol Friedewald 4th | 2.60 | 0 - 3.34 | mmol/L | ||||||||
| 276 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | RETICULOCYTES | Reticulocyte Count % | 1.2 | 0.6 - 2.5 | % | ||||||||
| 277 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | TSH | TSH 3rd IS-QT | 0.976 | 0.45 - 5.33 | mIU/L | ||||||||
| 278 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | URINE MACRO PANEL | Ur Specific Gravity | 1.016 | 1 - 1.04 | |||||||||
| 279 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | URINE MACRO PANEL | Ur pH | 6.0 | 5 - 8 | |||||||||
| 280 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 281 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 282 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 283 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 284 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 285 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 286 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 287 | CZ100120004 | 39 | years | Male | Part 2 DB Every 12 Weeks | Mar 6, 2026 2:00 PM | 6226560891 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 288 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.3 | 0 - 5 | mg/L | ||||||||
| 289 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Total Bilirubin | 10 | 3 - 21 | umol/L | ||||||||
| 290 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.4 | 0 - 6.2 | umol/L | ||||||||
| 291 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Alkaline Phosphatase | 55 | 35 - 104 | U/L | ||||||||
| 292 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | ALT (SGPT) | 14 | 4 - 43 | U/L | ||||||||
| 293 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | AST (SGOT) | 17 | 8 - 40 | U/L | ||||||||
| 294 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | GGT | 21 | 5 - 50 | U/L | ||||||||
| 295 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | LDH | 136 | 53 - 234 | U/L | ||||||||
| 296 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Urea Nitrogen | 4.1 | 1.4 - 8.6 | mmol/L | ||||||||
| 297 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 80 | 31 - 101 | umol/L | ||||||||
| 298 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Glucose Fasting | 5.1 | 3.9 - 5.6 | mmol/L | ||||||||
| 299 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Serum Uric Acid | 273 | 149 - 446 | umol/L | ||||||||
| 300 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Calcium (EDTA) | 2.49 | 2.07 - 2.64 | mmol/L | ||||||||
| 301 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Phosphorus | 1.13 | 0.71 - 1.65 | mmol/L | ||||||||
| 302 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Total Protein | 69 | 60 - 80 | g/L | ||||||||
| 303 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | ||||||||
| 304 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Creatine Kinase | 42 | 26 - 192 | U/L | ||||||||
| 305 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Serum Sodium | 142 | 135 - 145 | mmol/L | ||||||||
| 306 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Serum Potassium | 4.7 | 3.5 - 5.2 | mmol/L | ||||||||
| 307 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Serum Bicarbonate | 24.2 | 19.3 - 29.3 | mmol/L | ||||||||
| 308 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | ||||||||
| 309 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 122 | 115 - 158 | g/L | ||||||||
| 310 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.37 | 0.34 - 0.48 | |||||||||
| 311 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.0 | 3.9 - 5.5 | TI/L | ||||||||
| 312 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 313 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 92 | 80 - 100 | fL | ||||||||
| 314 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.67 | 3.8 - 10.7 | GI/L | ||||||||
| 315 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.77 | 1.96 - 7.23 | GI/L | ||||||||
| 316 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.32 | 0.8 - 3 | GI/L | ||||||||
| 317 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.33 | 0.12 - 0.92 | GI/L | ||||||||
| 318 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.19 | 0 - 0.57 | GI/L | ||||||||
| 319 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.07 | 0 - 0.2 | GI/L | ||||||||
| 320 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 59.2 | 40.5 - 75 | % | ||||||||
| 321 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 28.3 | 15.4 - 48.5 | % | ||||||||
| 322 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.0 | 2.6 - 10.1 | % | ||||||||
| 323 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 4.0 | 0 - 6.8 | % | ||||||||
| 324 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.5 | 0 - 2 | % | ||||||||
| 325 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 453 | H | 130 - 394 | GI/L | |||||||
| 326 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 14.65 | 1.9 - 23 | uIU/mL | ||||||||
| 327 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 328 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | LIPID PANEL | Direct HDL-C 4th Generation | 1.00 | L | 1.03 - 1.53 | mmol/L | |||||||
| 329 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | LIPID PANEL | Triglycerides (GPO) | 1.31 | 0.63 - 2.71 | mmol/L | ||||||||
| 330 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | LIPID PANEL | Cholesterol (High Performance) | 4.11 | L | 4.86 - 8.28 | mmol/L | |||||||
| 331 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | LIPID PANEL | LDL Chol Friedewald 4th | 2.51 | 0 - 3.34 | mmol/L | ||||||||
| 332 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | RETICULOCYTES | Reticulocyte Count % | 0.9 | 0.6 - 2.5 | % | ||||||||
| 333 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | URINE MACRO PANEL | Ur Specific Gravity | 1.019 | 1.01 - 1.03 | |||||||||
| 334 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | URINE MACRO PANEL | Ur pH | 6.5 | 5 - 8 | |||||||||
| 335 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 336 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 337 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 338 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 339 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 340 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 341 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 342 | CZ100120005 | 65 | years | Female | Part 1 DB Baseline | Feb 15, 2026 3:10 PM | 6227775508 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 343 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | C-REACTIVE PROTEIN | C Reactive Protein HS | <0.2 | Result verified by repeat analysis | 0 - 5 | mg/L | |||||||
| 344 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Total Bilirubin | 5 | 3 - 21 | umol/L | ||||||||
| 345 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.3 | 0 - 6.2 | umol/L | ||||||||
| 346 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Alkaline Phosphatase | 55 | 40 - 129 | U/L | ||||||||
| 347 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | ALT (SGPT) | 24 | 5 - 48 | U/L | ||||||||
| 348 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | AST (SGOT) | 21 | 8 - 40 | U/L | ||||||||
| 349 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | GGT | 12 | 10 - 61 | U/L | ||||||||
| 350 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | LDH | 133 | 53 - 234 | U/L | ||||||||
| 351 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Urea Nitrogen | 3.9 | 1.4 - 8.6 | mmol/L | ||||||||
| 352 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 72 | 40 - 110 | umol/L | ||||||||
| 353 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Glucose Fasting | 4.9 | 3.9 - 5.6 | mmol/L | ||||||||
| 354 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Serum Uric Acid | 244 | 125 - 488 | umol/L | ||||||||
| 355 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Calcium (EDTA) | 2.40 | 2.07 - 2.64 | mmol/L | ||||||||
| 356 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Phosphorus | 1.06 | 0.71 - 1.65 | mmol/L | ||||||||
| 357 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Total Protein | 63 | 61 - 84 | g/L | ||||||||
| 358 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | ||||||||
| 359 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Creatine Kinase | 139 | 39 - 308 | U/L | ||||||||
| 360 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Serum Sodium | 141 | 132 - 147 | mmol/L | ||||||||
| 361 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||
| 362 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Serum Bicarbonate | 22.9 | 19.3 - 29.3 | mmol/L | ||||||||
| 363 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | CHEMISTRY PANEL | Serum Chloride | 106 | 94 - 112 | mmol/L | ||||||||
| 364 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 156 | 127 - 181 | g/L | ||||||||
| 365 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.45 | 0.39 - 0.54 | |||||||||
| 366 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.0 | 4.5 - 6.4 | TI/L | ||||||||
| 367 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 368 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 89 | 79 - 96 | fL | ||||||||
| 369 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 3.41 | L | 3.8 - 10.7 | GI/L | |||||||
| 370 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 1.63 | L | 1.96 - 7.23 | GI/L | |||||||
| 371 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.42 | 0.91 - 4.28 | GI/L | ||||||||
| 372 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.22 | 0.12 - 0.92 | GI/L | ||||||||
| 373 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.08 | 0 - 0.57 | GI/L | ||||||||
| 374 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||
| 375 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 47.9 | 40.5 - 75 | % | ||||||||
| 376 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 41.7 | 15.4 - 48.5 | % | ||||||||
| 377 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.6 | 2.6 - 10.1 | % | ||||||||
| 378 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.3 | 0 - 6.8 | % | ||||||||
| 379 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.6 | 0 - 2 | % | ||||||||
| 380 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 160 | 140 - 400 | GI/L | ||||||||
| 381 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 4.99 | 1.9 - 23 | uIU/mL | ||||||||
| 382 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 383 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | LIPID PANEL | Direct HDL-C 4th Generation | 1.32 | 1.03 - 1.53 | mmol/L | ||||||||
| 384 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | LIPID PANEL | Triglycerides (GPO) | 0.52 | 0.5 - 2.81 | mmol/L | ||||||||
| 385 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | LIPID PANEL | Cholesterol (High Performance) | 3.73 | 3.31 - 6.1 | mmol/L | ||||||||
| 386 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | LIPID PANEL | LDL Chol Friedewald 4th | 2.17 | 0 - 3.34 | mmol/L | ||||||||
| 387 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | RETICULOCYTES | Reticulocyte Count % | 0.7 | 0.6 - 2.5 | % | ||||||||
| 388 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | URINE MACRO PANEL | Ur Specific Gravity | 1.006 | 1 - 1.04 | |||||||||
| 389 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | URINE MACRO PANEL | Ur pH | 6.0 | 5 - 8 | |||||||||
| 390 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 391 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 392 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 393 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 394 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 395 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 396 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 397 | CZ100120006 | 27 | years | Male | Part 1 DB Baseline | Feb 15, 2026 1:30 PM | 6227775507 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 398 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | C-REACTIVE PROTEIN | C Reactive Protein HS | <0.2 | Result verified by repeat analysis | 0 - 5 | mg/L | |||||||
| 399 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Total Bilirubin | 4 | 3 - 21 | umol/L | ||||||||
| 400 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.9 | 0 - 6.2 | umol/L | ||||||||
| 401 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Alkaline Phosphatase | 57 | 40 - 129 | U/L | ||||||||
| 402 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | ALT (SGPT) | 22 | 5 - 48 | U/L | ||||||||
| 403 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | AST (SGOT) | 21 | 8 - 40 | U/L | ||||||||
| 404 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | GGT | 11 | 10 - 61 | U/L | ||||||||
| 405 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | LDH | 131 | 53 - 234 | U/L | ||||||||
| 406 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Urea Nitrogen | 5.8 | 1.4 - 8.6 | mmol/L | ||||||||
| 407 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 76 | 40 - 110 | umol/L | ||||||||
| 408 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Glucose Fasting | 4.4 | 3.9 - 5.6 | mmol/L | ||||||||
| 409 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Serum Uric Acid | 300 | 125 - 488 | umol/L | ||||||||
| 410 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Calcium (EDTA) | 2.33 | 2.07 - 2.64 | mmol/L | ||||||||
| 411 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Phosphorus | 1.05 | 0.71 - 1.65 | mmol/L | ||||||||
| 412 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Total Protein | 62 | 61 - 84 | g/L | ||||||||
| 413 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | ||||||||
| 414 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Creatine Kinase | 120 | 39 - 308 | U/L | ||||||||
| 415 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||
| 416 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Serum Potassium | 4.8 | 3.5 - 5.2 | mmol/L | ||||||||
| 417 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Serum Bicarbonate | 25.3 | 19.3 - 29.3 | mmol/L | ||||||||
| 418 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CHEMISTRY PANEL | Serum Chloride | 105 | 94 - 112 | mmol/L | ||||||||
| 419 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 2.28 | H | 1.42 - 2.08 | mL/sec | |||||||
| 420 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 76 | 40 - 110 | umol/L | ||||||||
| 421 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 75.0 | kg | ||||||||
| 422 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 423 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 424 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 425 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 426 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 427 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 428 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 429 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | GFR | EGFR by MDRD | 107 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 430 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 152 | 127 - 181 | g/L | ||||||||
| 431 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.45 | 0.39 - 0.54 | |||||||||
| 432 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.0 | 4.5 - 6.4 | TI/L | ||||||||
| 433 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 434 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 90 | 79 - 96 | fL | ||||||||
| 435 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.30 | 3.8 - 10.7 | GI/L | ||||||||
| 436 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.90 | 1.96 - 7.23 | GI/L | ||||||||
| 437 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.77 | 0.91 - 4.28 | GI/L | ||||||||
| 438 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.35 | 0.12 - 0.92 | GI/L | ||||||||
| 439 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.14 | 0 - 0.57 | GI/L | ||||||||
| 440 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.14 | 0 - 0.2 | GI/L | ||||||||
| 441 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 54.7 | 40.5 - 75 | % | ||||||||
| 442 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 33.3 | 15.4 - 48.5 | % | ||||||||
| 443 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.6 | 2.6 - 10.1 | % | ||||||||
| 444 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.7 | 0 - 6.8 | % | ||||||||
| 445 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 2.6 | H | 0 - 2 | % | |||||||
| 446 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 189 | 140 - 400 | GI/L | ||||||||
| 447 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 4.9 | <6.5 % | |||||||||
| 448 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 3.16 | 1.9 - 23 | uIU/mL | ||||||||
| 449 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 450 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 451 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | LIPID PANEL | Direct HDL-C 4th Generation | 1.43 | 1.03 - 1.53 | mmol/L | ||||||||
| 452 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | LIPID PANEL | Triglycerides (GPO) | 0.61 | 0.5 - 2.81 | mmol/L | ||||||||
| 453 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | LIPID PANEL | Cholesterol (High Performance) | 3.71 | 3.31 - 6.1 | mmol/L | ||||||||
| 454 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | LIPID PANEL | LDL Chol Friedewald 4th | 2.00 | 0 - 3.34 | mmol/L | ||||||||
| 455 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | RETICULOCYTES | Reticulocyte Count % | 1.1 | 0.6 - 2.5 | % | ||||||||
| 456 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | TSH | TSH 3rd IS-QT | 1.462 | 0.45 - 5.33 | mIU/L | ||||||||
| 457 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | URINE MACRO PANEL | Ur Specific Gravity | 1.009 | 1 - 1.04 | |||||||||
| 458 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | URINE MACRO PANEL | Ur pH | 6.0 | 5 - 8 | |||||||||
| 459 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 460 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 461 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 462 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 463 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 464 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 465 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 466 | CZ100120006 | 27 | years | Male | Part 1 Screening | Feb 1, 2026 12:25 PM | 6227767267 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 467 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | BENZODIAZEPINE CONFIRM. UR | BenzodiazepineConf-LCMSMS-LDT | Temazepam (Confirmed) | RX | No Ref Rng | ||||||||
| 468 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | BENZODIAZEPINE CONFIRM. UR | BenzodiazepineConf-LCMSMS-LDT | Oxazepam (Confirmed) | RX | No Ref Rng | ||||||||
| 469 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.3 | 0 - 5 | mg/L | ||||||||
| 470 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Total Bilirubin | 4 | 3 - 21 | umol/L | ||||||||
| 471 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.5 | 0 - 6.2 | umol/L | ||||||||
| 472 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Alkaline Phosphatase | 55 | 35 - 104 | U/L | ||||||||
| 473 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | ALT (SGPT) | 11 | 4 - 43 | U/L | ||||||||
| 474 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | AST (SGOT) | 17 | 8 - 40 | U/L | ||||||||
| 475 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | GGT | 21 | 5 - 50 | U/L | ||||||||
| 476 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | LDH | 136 | 53 - 234 | U/L | ||||||||
| 477 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Urea Nitrogen | 4.3 | 1.4 - 8.6 | mmol/L | ||||||||
| 478 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 77 | 31 - 101 | umol/L | ||||||||
| 479 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Glucose Fasting | 4.8 | 3.9 - 5.6 | mmol/L | ||||||||
| 480 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Serum Uric Acid | 247 | 149 - 446 | umol/L | ||||||||
| 481 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Calcium (EDTA) | 2.40 | 2.07 - 2.64 | mmol/L | ||||||||
| 482 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Phosphorus | 1.20 | 0.71 - 1.65 | mmol/L | ||||||||
| 483 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Total Protein | 68 | 60 - 80 | g/L | ||||||||
| 484 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | ||||||||
| 485 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Creatine Kinase | 44 | 26 - 192 | U/L | ||||||||
| 486 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Serum Sodium | 142 | 135 - 145 | mmol/L | ||||||||
| 487 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Serum Potassium | 4.5 | 3.5 - 5.2 | mmol/L | ||||||||
| 488 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Serum Bicarbonate | 23.5 | 19.3 - 29.3 | mmol/L | ||||||||
| 489 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||
| 490 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 1.25 | 1.25 - 1.92 | mL/sec | ||||||||
| 491 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 77 | 31 - 101 | umol/L | ||||||||
| 492 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 74.0 | kg | ||||||||
| 493 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 494 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 495 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 496 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 497 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 498 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 499 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Detected (unconfirmed) | Neg;$Cutoff = 200 ng/mL | |||||||||
| 500 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | No | |||||||||
| 501 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | FSH | Follicle Stimulating Hormone | 55.96 | Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L | |||||||||
| 502 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | GFR | EGFR by MDRD | 65 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 503 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 119 | 115 - 158 | g/L | ||||||||
| 504 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.36 | 0.34 - 0.48 | |||||||||
| 505 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 3.9 | 3.9 - 5.5 | TI/L | ||||||||
| 506 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 507 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 92 | 80 - 100 | fL | ||||||||
| 508 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.94 | 3.8 - 10.7 | GI/L | ||||||||
| 509 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.50 | 1.96 - 7.23 | GI/L | ||||||||
| 510 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.91 | 0.8 - 3 | GI/L | ||||||||
| 511 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.40 | 0.12 - 0.92 | GI/L | ||||||||
| 512 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.10 | 0 - 0.57 | GI/L | ||||||||
| 513 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | 0 - 0.2 | GI/L | ||||||||
| 514 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 64.8 | 40.5 - 75 | % | ||||||||
| 515 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 27.5 | 15.4 - 48.5 | % | ||||||||
| 516 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.8 | 2.6 - 10.1 | % | ||||||||
| 517 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.5 | 0 - 6.8 | % | ||||||||
| 518 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.4 | 0 - 2 | % | ||||||||
| 519 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 448 | R | H | 130 - 394 | GI/L | ||||||
| 520 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.5 | <6.5 % | |||||||||
| 521 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 5.62 | 1.9 - 23 | uIU/mL | ||||||||
| 522 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 523 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 524 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | LIPID PANEL | Direct HDL-C 4th Generation | 1.02 | R | L | 1.03 - 1.53 | mmol/L | ||||||
| 525 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | LIPID PANEL | Triglycerides (GPO) | 1.44 | 0.63 - 2.71 | mmol/L | ||||||||
| 526 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | LIPID PANEL | Cholesterol (High Performance) | 4.25 | R | L | 4.86 - 8.28 | mmol/L | ||||||
| 527 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | LIPID PANEL | LDL Chol Friedewald 4th | 2.57 | 0 - 3.34 | mmol/L | ||||||||
| 528 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | Yes | ||||||||||
| 529 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | RETICULOCYTES | Reticulocyte Count % | 0.7 | 0.6 - 2.5 | % | ||||||||
| 530 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | TSH | TSH 3rd IS-QT | 0.834 | 0.45 - 5.33 | mIU/L | ||||||||
| 531 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | URINE MACRO PANEL | Ur Specific Gravity | 1.007 | 1.01 - 1.03 | |||||||||
| 532 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 533 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 534 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 535 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 536 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 537 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 538 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 539 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 540 | CZ100120005 | 65 | years | Female | Part 1 Screening | Jan 28, 2026 4:50 PM | 6227775505 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 541 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | C-REACTIVE PROTEIN | C Reactive Protein HS | 4.8 | 0 - 5 | mg/L | ||||||||
| 542 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Total Bilirubin | 10 | 3 - 21 | umol/L | ||||||||
| 543 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.3 | 0 - 6.2 | umol/L | ||||||||
| 544 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Alkaline Phosphatase | 70 | 40 - 129 | U/L | ||||||||
| 545 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | ALT (SGPT) | 41 | 5 - 48 | U/L | ||||||||
| 546 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | AST (SGOT) | 27 | 8 - 40 | U/L | ||||||||
| 547 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | GGT | 81 | H | 10 - 61 | U/L | |||||||
| 548 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | LDH | 92 | 53 - 234 | U/L | ||||||||
| 549 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Urea Nitrogen | 3.3 | 1.4 - 8.6 | mmol/L | ||||||||
| 550 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 74 | 40 - 110 | umol/L | ||||||||
| 551 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Glucose Fasting | 6.1 | H | 3.9 - 5.6 | mmol/L | |||||||
| 552 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Serum Uric Acid | 412 | 125 - 488 | umol/L | ||||||||
| 553 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Calcium (EDTA) | 2.37 | 2.07 - 2.64 | mmol/L | ||||||||
| 554 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Phosphorus | 0.94 | 0.71 - 1.65 | mmol/L | ||||||||
| 555 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Total Protein | 67 | 61 - 84 | g/L | ||||||||
| 556 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | ||||||||
| 557 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Creatine Kinase | 148 | 39 - 308 | U/L | ||||||||
| 558 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 559 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||
| 560 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Serum Bicarbonate | 25.4 | 19.3 - 29.3 | mmol/L | ||||||||
| 561 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||
| 562 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 153 | 127 - 181 | g/L | ||||||||
| 563 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.43 | 0.39 - 0.54 | |||||||||
| 564 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.0 | 4.5 - 6.4 | TI/L | ||||||||
| 565 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 566 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 86 | 79 - 96 | fL | ||||||||
| 567 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.61 | 3.8 - 10.7 | GI/L | ||||||||
| 568 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.00 | 1.96 - 7.23 | GI/L | ||||||||
| 569 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.02 | 0.91 - 4.28 | GI/L | ||||||||
| 570 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.40 | 0.12 - 0.92 | GI/L | ||||||||
| 571 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.14 | 0 - 0.57 | GI/L | ||||||||
| 572 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.05 | 0 - 0.2 | GI/L | ||||||||
| 573 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 60.5 | 40.5 - 75 | % | ||||||||
| 574 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 30.5 | 15.4 - 48.5 | % | ||||||||
| 575 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.0 | 2.6 - 10.1 | % | ||||||||
| 576 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.2 | 0 - 6.8 | % | ||||||||
| 577 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.7 | 0 - 2 | % | ||||||||
| 578 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 322 | 140 - 400 | GI/L | ||||||||
| 579 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 63.81 | H | 1.9 - 23 | uIU/mL | |||||||
| 580 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 581 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | LIPID PANEL | Direct HDL-C 4th Generation | 1.13 | 1.03 - 1.53 | mmol/L | ||||||||
| 582 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | LIPID PANEL | Triglycerides (GPO) | 2.66 | 0.56 - 3.62 | mmol/L | ||||||||
| 583 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | LIPID PANEL | Cholesterol (High Performance) | 4.84 | 3.88 - 6.83 | mmol/L | ||||||||
| 584 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | LIPID PANEL | LDL Chol Friedewald 4th | 2.49 | 0 - 3.34 | mmol/L | ||||||||
| 585 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | RETICULOCYTES | Reticulocyte Count % | 1.1 | 0.6 - 2.5 | % | ||||||||
| 586 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | URINE MACRO PANEL | Ur Specific Gravity | 1.022 | 1 - 1.04 | |||||||||
| 587 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 588 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 589 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 590 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 591 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 592 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 593 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 594 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 595 | CZ100120004 | 39 | years | Male | Part 2 OL Induction Day 29 | Jan 2, 2026 12:00 PM | 6226976943 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 596 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | C-REACTIVE PROTEIN | C Reactive Protein HS | 4.0 | 0 - 5 | mg/L | ||||||||
| 597 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Total Bilirubin | 9 | 3 - 21 | umol/L | ||||||||
| 598 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.8 | 0 - 6.2 | umol/L | ||||||||
| 599 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Alkaline Phosphatase | 74 | 40 - 129 | U/L | ||||||||
| 600 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | ALT (SGPT) | 42 | 5 - 48 | U/L | ||||||||
| 601 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | AST (SGOT) | 26 | 8 - 40 | U/L | ||||||||
| 602 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | GGT | 70 | H | 10 - 61 | U/L | |||||||
| 603 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | LDH | 89 | 53 - 234 | U/L | ||||||||
| 604 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Urea Nitrogen | 3.1 | 1.4 - 8.6 | mmol/L | ||||||||
| 605 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 77 | 40 - 110 | umol/L | ||||||||
| 606 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Glucose Fasting | 6.6 | R | H | 3.9 - 5.6 | mmol/L | ||||||
| 607 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Serum Uric Acid | 418 | 125 - 488 | umol/L | ||||||||
| 608 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Calcium (EDTA) | 2.38 | 2.07 - 2.64 | mmol/L | ||||||||
| 609 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Phosphorus | 0.91 | 0.71 - 1.65 | mmol/L | ||||||||
| 610 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Total Protein | 72 | 61 - 84 | g/L | ||||||||
| 611 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | ||||||||
| 612 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Creatine Kinase | 100 | 39 - 308 | U/L | ||||||||
| 613 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||
| 614 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Serum Potassium | 4.0 | 3.5 - 5.2 | mmol/L | ||||||||
| 615 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Serum Bicarbonate | 26.3 | 19.3 - 29.3 | mmol/L | ||||||||
| 616 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||
| 617 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 153 | 127 - 181 | g/L | ||||||||
| 618 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.43 | 0.39 - 0.54 | |||||||||
| 619 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.1 | 4.5 - 6.4 | TI/L | ||||||||
| 620 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 621 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 84 | 79 - 96 | fL | ||||||||
| 622 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.86 | 3.8 - 10.7 | GI/L | ||||||||
| 623 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.10 | 1.96 - 7.23 | GI/L | ||||||||
| 624 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.01 | 0.91 - 4.28 | GI/L | ||||||||
| 625 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.39 | 0.12 - 0.92 | GI/L | ||||||||
| 626 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.30 | 0 - 0.57 | GI/L | ||||||||
| 627 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.07 | 0 - 0.2 | GI/L | ||||||||
| 628 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 59.8 | 40.5 - 75 | % | ||||||||
| 629 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 29.2 | 15.4 - 48.5 | % | ||||||||
| 630 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.7 | 2.6 - 10.1 | % | ||||||||
| 631 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 4.3 | 0 - 6.8 | % | ||||||||
| 632 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.0 | 0 - 2 | % | ||||||||
| 633 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 374 | 140 - 400 | GI/L | ||||||||
| 634 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | HEMOGLOBIN A1C | Hemoglobin A1c,NGSP-RM | 5.7 | <6.5 % | |||||||||
| 635 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 196.11 | H | 1.9 - 23 | uIU/mL | |||||||
| 636 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 637 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | LIPID PANEL | Direct HDL-C 4th Generation | 0.97 | L | 1.03 - 1.53 | mmol/L | |||||||
| 638 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | LIPID PANEL | Triglycerides (GPO) | 2.92 | 0.56 - 3.62 | mmol/L | ||||||||
| 639 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | LIPID PANEL | Cholesterol (High Performance) | 4.31 | 3.88 - 6.83 | mmol/L | ||||||||
| 640 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | LIPID PANEL | LDL Chol Friedewald 4th | 2.00 | 0 - 3.34 | mmol/L | ||||||||
| 641 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | RETICULOCYTES | Reticulocyte Count % | 0.9 | 0.6 - 2.5 | % | ||||||||
| 642 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | TSH | TSH 3rd IS-QT | 0.889 | 0.45 - 5.33 | mIU/L | ||||||||
| 643 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | URINE MACRO PANEL | Ur Specific Gravity | 1.011 | 1 - 1.04 | |||||||||
| 644 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 645 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 646 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 647 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 648 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 649 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 650 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 651 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 652 | CZ100120004 | 39 | years | Male | End of Phase/Treatment | Dec 5, 2025 3:00 PM | 6225351126 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 653 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | C-REACTIVE PROTEIN | C Reactive Protein HS | 3.6 | 0 - 5 | mg/L | ||||||||
| 654 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Total Bilirubin | 8 | 3 - 21 | umol/L | ||||||||
| 655 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.9 | 0 - 6.2 | umol/L | ||||||||
| 656 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Alkaline Phosphatase | 67 | 40 - 129 | U/L | ||||||||
| 657 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | ALT (SGPT) | 34 | 5 - 48 | U/L | ||||||||
| 658 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | AST (SGOT) | 20 | 8 - 40 | U/L | ||||||||
| 659 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | GGT | 69 | H | 10 - 61 | U/L | |||||||
| 660 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | LDH | 98 | 53 - 234 | U/L | ||||||||
| 661 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Urea Nitrogen | 2.2 | 1.4 - 8.6 | mmol/L | ||||||||
| 662 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 75 | 40 - 110 | umol/L | ||||||||
| 663 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Glucose Fasting | 5.6 | 3.9 - 5.6 | mmol/L | ||||||||
| 664 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Serum Uric Acid | 520 | R | H | 125 - 488 | umol/L | ||||||
| 665 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Calcium (EDTA) | 2.37 | 2.07 - 2.64 | mmol/L | ||||||||
| 666 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Phosphorus | 1.19 | 0.71 - 1.65 | mmol/L | ||||||||
| 667 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Total Protein | 65 | 61 - 84 | g/L | ||||||||
| 668 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Albumin-BCG | 44 | 33 - 49 | g/L | ||||||||
| 669 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Creatine Kinase | 126 | 39 - 308 | U/L | ||||||||
| 670 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Serum Sodium | 142 | 132 - 147 | mmol/L | ||||||||
| 671 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Serum Potassium | 4.0 | 3.5 - 5.2 | mmol/L | ||||||||
| 672 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Serum Bicarbonate | 21.4 | 19.3 - 29.3 | mmol/L | ||||||||
| 673 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | CHEMISTRY PANEL | Serum Chloride | 104 | 94 - 112 | mmol/L | ||||||||
| 674 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 146 | 127 - 181 | g/L | ||||||||
| 675 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.42 | 0.39 - 0.54 | |||||||||
| 676 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.9 | 4.5 - 6.4 | TI/L | ||||||||
| 677 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 678 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 86 | 79 - 96 | fL | ||||||||
| 679 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.43 | 3.8 - 10.7 | GI/L | ||||||||
| 680 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.49 | 1.96 - 7.23 | GI/L | ||||||||
| 681 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.20 | 0.91 - 4.28 | GI/L | ||||||||
| 682 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.44 | 0.12 - 0.92 | GI/L | ||||||||
| 683 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.24 | 0 - 0.57 | GI/L | ||||||||
| 684 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.04 | 0 - 0.2 | GI/L | ||||||||
| 685 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 54.4 | 40.5 - 75 | % | ||||||||
| 686 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 34.2 | 15.4 - 48.5 | % | ||||||||
| 687 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.9 | 2.6 - 10.1 | % | ||||||||
| 688 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 3.8 | 0 - 6.8 | % | ||||||||
| 689 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.7 | 0 - 2 | % | ||||||||
| 690 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 288 | 140 - 400 | GI/L | ||||||||
| 691 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 15.24 | 1.9 - 23 | uIU/mL | ||||||||
| 692 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 693 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | LIPID PANEL | Direct HDL-C 4th Generation | 1.15 | 1.03 - 1.53 | mmol/L | ||||||||
| 694 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | LIPID PANEL | Triglycerides (GPO) | 1.64 | 0.56 - 3.62 | mmol/L | ||||||||
| 695 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | LIPID PANEL | Cholesterol (High Performance) | 4.19 | 3.88 - 6.83 | mmol/L | ||||||||
| 696 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | LIPID PANEL | LDL Chol Friedewald 4th | 2.29 | 0 - 3.34 | mmol/L | ||||||||
| 697 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | RETICULOCYTES | Reticulocyte Count % | 1.3 | 0.6 - 2.5 | % | ||||||||
| 698 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | URINE MACRO PANEL | Ur Specific Gravity | 1.011 | 1 - 1.04 | |||||||||
| 699 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | URINE MACRO PANEL | Ur pH | 5.0 | 5 - 8 | |||||||||
| 700 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 701 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 702 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 703 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 704 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 705 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 706 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 707 | CZ100120004 | 39 | years | Male | Part 1 DB Baseline | Oct 22, 2025 12:15 PM | 6225351120 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 708 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | C-REACTIVE PROTEIN | C Reactive Protein HS | 3.6 | 0 - 5 | mg/L | ||||||||
| 709 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Total Bilirubin | 8 | 3 - 21 | umol/L | ||||||||
| 710 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 3.2 | 0 - 6.2 | umol/L | ||||||||
| 711 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Alkaline Phosphatase | 65 | 40 - 129 | U/L | ||||||||
| 712 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | ALT (SGPT) | 36 | 5 - 48 | U/L | ||||||||
| 713 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | AST (SGOT) | 26 | 8 - 40 | U/L | ||||||||
| 714 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | GGT | 62 | H | 10 - 61 | U/L | |||||||
| 715 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | LDH | 105 | 53 - 234 | U/L | ||||||||
| 716 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Urea Nitrogen | 2.2 | 1.4 - 8.6 | mmol/L | ||||||||
| 717 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 77 | 40 - 110 | umol/L | ||||||||
| 718 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Glucose Fasting | 5.8 | H | 3.9 - 5.6 | mmol/L | |||||||
| 719 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Serum Uric Acid | 472 | 125 - 488 | umol/L | ||||||||
| 720 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Calcium (EDTA) | 2.36 | 2.07 - 2.64 | mmol/L | ||||||||
| 721 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Phosphorus | 1.14 | 0.71 - 1.65 | mmol/L | ||||||||
| 722 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Total Protein | 69 | 61 - 84 | g/L | ||||||||
| 723 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||
| 724 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Creatine Kinase | 132 | 39 - 308 | U/L | ||||||||
| 725 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Serum Sodium | 141 | 132 - 147 | mmol/L | ||||||||
| 726 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||
| 727 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Serum Bicarbonate | 21.0 | 19.3 - 29.3 | mmol/L | ||||||||
| 728 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||
| 729 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 3.53 | H | 1.42 - 2.08 | mL/sec | |||||||
| 730 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 77 | 40 - 110 | umol/L | ||||||||
| 731 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 130.2 | kg | ||||||||
| 732 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 733 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 734 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 735 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 736 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 737 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 738 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 739 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | GFR | EGFR by MDRD | 98 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 740 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 148 | 127 - 181 | g/L | ||||||||
| 741 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.42 | 0.39 - 0.54 | |||||||||
| 742 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.0 | 4.5 - 6.4 | TI/L | ||||||||
| 743 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 744 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 85 | 79 - 96 | fL | ||||||||
| 745 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.89 | 3.8 - 10.7 | GI/L | ||||||||
| 746 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.47 | 1.96 - 7.23 | GI/L | ||||||||
| 747 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.93 | 0.91 - 4.28 | GI/L | ||||||||
| 748 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.30 | 0.12 - 0.92 | GI/L | ||||||||
| 749 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.17 | 0 - 0.57 | GI/L | ||||||||
| 750 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.02 | 0 - 0.2 | GI/L | ||||||||
| 751 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 58.8 | 40.5 - 75 | % | ||||||||
| 752 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 32.7 | 15.4 - 48.5 | % | ||||||||
| 753 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.1 | 2.6 - 10.1 | % | ||||||||
| 754 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.9 | 0 - 6.8 | % | ||||||||
| 755 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.4 | 0 - 2 | % | ||||||||
| 756 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 369 | 140 - 400 | GI/L | ||||||||
| 757 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 5.5 | <6.5% | |||||||||
| 758 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 16.15 | 1.9 - 23 | uIU/mL | ||||||||
| 759 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 760 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 761 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | LIPID PANEL | Direct HDL-C 4th Generation | 1.24 | 1.03 - 1.53 | mmol/L | ||||||||
| 762 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | LIPID PANEL | Triglycerides (GPO) | 1.40 | 0.56 - 3.62 | mmol/L | ||||||||
| 763 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | LIPID PANEL | Cholesterol (High Performance) | 4.07 | 3.88 - 6.83 | mmol/L | ||||||||
| 764 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | LIPID PANEL | LDL Chol Friedewald 4th | 2.19 | 0 - 3.34 | mmol/L | ||||||||
| 765 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | RETICULOCYTES | Reticulocyte Count % | 1.0 | 0.6 - 2.5 | % | ||||||||
| 766 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | TSH | TSH 3rd IS-QT | 1.099 | 0.45 - 5.33 | mIU/L | ||||||||
| 767 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | URINE MACRO PANEL | Ur Specific Gravity | 1.017 | 1 - 1.04 | |||||||||
| 768 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | URINE MACRO PANEL | Ur pH | 5.0 | 5 - 8 | |||||||||
| 769 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 770 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 771 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 772 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 773 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 774 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:Negative | |||||||||
| 775 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 776 | CZ100120004 | 39 | years | Male | Part 1 Screening | Oct 1, 2025 1:00 PM | 6225351111 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 777 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.4 | 0 - 5 | mg/L | ||||||||
| 778 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Total Bilirubin | 7 | 3 - 21 | umol/L | ||||||||
| 779 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.4 | 0 - 6.2 | umol/L | ||||||||
| 780 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Alkaline Phosphatase | 84 | 35 - 104 | U/L | ||||||||
| 781 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | ALT (SGPT) | 36 | 4 - 43 | U/L | ||||||||
| 782 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | AST (SGOT) | 24 | 8 - 40 | U/L | ||||||||
| 783 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | GGT | 44 | 4 - 49 | U/L | ||||||||
| 784 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | LDH | 220 | 53 - 234 | U/L | ||||||||
| 785 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Urea Nitrogen | 3.4 | 1.4 - 8.6 | mmol/L | ||||||||
| 786 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 58 | 31 - 101 | umol/L | ||||||||
| 787 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Glucose Fasting | 4.6 | 3.9 - 5.6 | mmol/L | ||||||||
| 788 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Serum Uric Acid | 295 | 125 - 428 | umol/L | ||||||||
| 789 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Calcium (EDTA) | 2.42 | 2.07 - 2.64 | mmol/L | ||||||||
| 790 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Phosphorus | 0.89 | 0.71 - 1.65 | mmol/L | ||||||||
| 791 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Total Protein | 77 | 61 - 84 | g/L | ||||||||
| 792 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||
| 793 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Creatine Kinase | 92 | 26 - 192 | U/L | ||||||||
| 794 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||
| 795 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||
| 796 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Serum Bicarbonate | 23.7 | 19.3 - 29.3 | mmol/L | ||||||||
| 797 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||
| 798 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 3.78 | H | 1.25 - 1.92 | mL/sec | |||||||
| 799 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 58 | 31 - 101 | umol/L | ||||||||
| 800 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 105.0 | kg | ||||||||
| 801 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 802 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 803 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 804 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 805 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 806 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 807 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 808 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | Yes | |||||||||
| 809 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | GFR | EGFR by MDRD | 114 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 810 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 137 | 116 - 164 | g/L | ||||||||
| 811 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.40 | 0.34 - 0.48 | |||||||||
| 812 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.6 | 4.1 - 5.6 | TI/L | ||||||||
| 813 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 814 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 88 | 79 - 98 | fL | ||||||||
| 815 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.91 | 3.8 - 10.7 | GI/L | ||||||||
| 816 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.15 | 1.96 - 7.23 | GI/L | ||||||||
| 817 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.38 | 0.91 - 4.28 | GI/L | ||||||||
| 818 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.33 | 0.12 - 0.92 | GI/L | ||||||||
| 819 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.04 | 0 - 0.57 | GI/L | ||||||||
| 820 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.01 | 0 - 0.2 | GI/L | ||||||||
| 821 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 70.3 | 40.5 - 75 | % | ||||||||
| 822 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 23.3 | 15.4 - 48.5 | % | ||||||||
| 823 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.6 | 2.6 - 10.1 | % | ||||||||
| 824 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 0.7 | 0 - 6.8 | % | ||||||||
| 825 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.1 | 0 - 2 | % | ||||||||
| 826 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 241 | 140 - 400 | GI/L | ||||||||
| 827 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 4.9 | <6.5% | |||||||||
| 828 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 15.68 | 1.9 - 23 | uIU/mL | ||||||||
| 829 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 830 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 831 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | LIPID PANEL | Direct HDL-C 4th Generation | 1.23 | 1.03 - 1.53 | mmol/L | ||||||||
| 832 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | LIPID PANEL | Triglycerides (GPO) | 1.78 | R | H | 0.41 - 1.63 | mmol/L | ||||||
| 833 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | LIPID PANEL | Cholesterol (High Performance) | 5.53 | 3.31 - 5.64 | mmol/L | ||||||||
| 834 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | LIPID PANEL | LDL Chol Friedewald 4th | 3.48 | H | 0 - 3.34 | mmol/L | |||||||
| 835 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | No | ||||||||||
| 836 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | RETICULOCYTES | Reticulocyte Count % | 2.0 | 0.6 - 2.5 | % | ||||||||
| 837 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | SERUM BETA HCG | B-hCG, Qualitative | Negative | Ref Rng: Negative | |||||||||
| 838 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | SERUM BETA HCG | B-hCG, Quantitative | <0.6 | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | |||||||||
| 839 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | TSH | TSH 3rd IS-QT | 2.503 | 0.45 - 5.33 | mIU/L | ||||||||
| 840 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | URINE MACRO PANEL | Ur Specific Gravity | 1.014 | 1 - 1.04 | |||||||||
| 841 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | URINE MACRO PANEL | Ur pH | 6.0 | 5 - 8 | |||||||||
| 842 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 843 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 844 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 845 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 846 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 847 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 848 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 849 | CZ100120003 | 21 | years | Female | Part 1 Screening | Oct 1, 2025 11:00 AM | 6225351110 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 850 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | C-REACTIVE PROTEIN | C Reactive Protein HS | 1.4 | 0 - 5 | mg/L | ||||||||
| 851 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Total Bilirubin | 4 | 3 - 21 | umol/L | ||||||||
| 852 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.7 | 0 - 6.2 | umol/L | ||||||||
| 853 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Alkaline Phosphatase | 69 | 35 - 104 | U/L | ||||||||
| 854 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | ALT (SGPT) | 5 | 4 - 43 | U/L | ||||||||
| 855 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | AST (SGOT) | 13 | 8 - 40 | U/L | ||||||||
| 856 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | GGT | <4 | L | Result verified by repeat analysis | 4 - 49 | U/L | ||||||
| 857 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | LDH | 143 | 53 - 234 | U/L | ||||||||
| 858 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Urea Nitrogen | 4.8 | 1.4 - 8.6 | mmol/L | ||||||||
| 859 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 56 | 31 - 101 | umol/L | ||||||||
| 860 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Glucose Fasting | 4.4 | 3.9 - 5.6 | mmol/L | ||||||||
| 861 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Serum Uric Acid | 193 | 125 - 428 | umol/L | ||||||||
| 862 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Calcium (EDTA) | 2.29 | 2.07 - 2.64 | mmol/L | ||||||||
| 863 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Phosphorus | 1.05 | 0.71 - 1.65 | mmol/L | ||||||||
| 864 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Total Protein | 67 | 61 - 84 | g/L | ||||||||
| 865 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Albumin-BCG | 43 | 33 - 49 | g/L | ||||||||
| 866 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Creatine Kinase | 75 | 26 - 192 | U/L | ||||||||
| 867 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Serum Sodium | 137 | 132 - 147 | mmol/L | ||||||||
| 868 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Serum Potassium | 4.5 | 3.5 - 5.2 | mmol/L | ||||||||
| 869 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Serum Bicarbonate | 21.2 | 19.3 - 29.3 | mmol/L | ||||||||
| 870 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||
| 871 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 2.06 | H | 1.25 - 1.92 | mL/sec | |||||||
| 872 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 56 | 31 - 101 | umol/L | ||||||||
| 873 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 65.8 | kg | ||||||||
| 874 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 875 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 876 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 877 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 878 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 879 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 880 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 881 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | Yes | |||||||||
| 882 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | GFR | EGFR by MDRD | 105 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 883 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 131 | 116 - 164 | g/L | ||||||||
| 884 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.39 | 0.34 - 0.48 | |||||||||
| 885 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.3 | 4.1 - 5.6 | TI/L | ||||||||
| 886 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 887 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 92 | 79 - 98 | fL | ||||||||
| 888 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.06 | 3.8 - 10.7 | GI/L | ||||||||
| 889 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 3.38 | 1.96 - 7.23 | GI/L | ||||||||
| 890 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.11 | 0.91 - 4.28 | GI/L | ||||||||
| 891 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.35 | 0.12 - 0.92 | GI/L | ||||||||
| 892 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.20 | 0 - 0.57 | GI/L | ||||||||
| 893 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | 0 - 0.2 | GI/L | ||||||||
| 894 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 66.7 | 40.5 - 75 | % | ||||||||
| 895 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 21.9 | 15.4 - 48.5 | % | ||||||||
| 896 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 6.8 | 2.6 - 10.1 | % | ||||||||
| 897 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 3.9 | 0 - 6.8 | % | ||||||||
| 898 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.6 | 0 - 2 | % | ||||||||
| 899 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 182 | 140 - 400 | GI/L | ||||||||
| 900 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 5.0 | <6.5% | |||||||||
| 901 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | Test cancelled: Hemolysis-test not performed | ||||||||||
| 902 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 903 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 904 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | LIPID PANEL | Direct HDL-C 4th Generation | 1.77 | R | H | 1.03 - 1.53 | mmol/L | ||||||
| 905 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | LIPID PANEL | Triglycerides (GPO) | 0.71 | 0.44 - 1.99 | mmol/L | ||||||||
| 906 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | LIPID PANEL | Cholesterol (High Performance) | 5.82 | 3.65 - 6.21 | mmol/L | ||||||||
| 907 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | LIPID PANEL | LDL Chol Friedewald 4th | 3.72 | H | 0 - 3.34 | mmol/L | |||||||
| 908 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | No | ||||||||||
| 909 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | RETICULOCYTES | Reticulocyte Count % | 1.7 | 0.6 - 2.5 | % | ||||||||
| 910 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | SERUM BETA HCG | B-hCG, Qualitative | Negative | Ref Rng: Negative | |||||||||
| 911 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | SERUM BETA HCG | B-hCG, Quantitative | <0.6 | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | |||||||||
| 912 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | TSH | TSH 3rd IS-QT | 1.847 | 0.45 - 5.33 | mIU/L | ||||||||
| 913 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | URINE MACRO PANEL | Ur Specific Gravity | 1.006 | 1 - 1.04 | |||||||||
| 914 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | URINE MACRO PANEL | Ur pH | 5.5 | 5 - 8 | |||||||||
| 915 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 916 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 917 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 918 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 919 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 920 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 921 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 922 | CZ100120002 | 40 | years | Female | Part 1 Screening | Sep 3, 2025 1:00 PM | 6225351109 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative | |||||||||
| 923 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | C-REACTIVE PROTEIN | C Reactive Protein HS | 4.6 | 0 - 5 | mg/L | ||||||||
| 924 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Total Bilirubin | 7 | 3 - 21 | umol/L | ||||||||
| 925 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.5 | 0 - 6.2 | umol/L | ||||||||
| 926 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Alkaline Phosphatase | 71 | 35 - 104 | U/L | ||||||||
| 927 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | ALT (SGPT) | 24 | 4 - 43 | U/L | ||||||||
| 928 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | AST (SGOT) | 31 | 8 - 40 | U/L | ||||||||
| 929 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | GGT | 79 | R | H | 4 - 49 | U/L | ||||||
| 930 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | LDH | 144 | 53 - 234 | U/L | ||||||||
| 931 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Urea Nitrogen | 4.3 | 1.4 - 8.6 | mmol/L | ||||||||
| 932 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 93 | 31 - 101 | umol/L | ||||||||
| 933 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Glucose Fasting | 4.8 | 3.9 - 5.6 | mmol/L | ||||||||
| 934 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Serum Uric Acid | 405 | 149 - 446 | umol/L | ||||||||
| 935 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Calcium (EDTA) | 2.38 | 2.07 - 2.64 | mmol/L | ||||||||
| 936 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Phosphorus | 0.92 | 0.71 - 1.65 | mmol/L | ||||||||
| 937 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Total Protein | 72 | 61 - 84 | g/L | ||||||||
| 938 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Albumin-BCG | 44 | 33 - 49 | g/L | ||||||||
| 939 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Creatine Kinase | 157 | 26 - 192 | U/L | ||||||||
| 940 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Serum Sodium | 138 | 132 - 147 | mmol/L | ||||||||
| 941 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Serum Potassium | 4.5 | 3.5 - 5.2 | mmol/L | ||||||||
| 942 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Serum Bicarbonate | 22.8 | 19.3 - 29.3 | mmol/L | ||||||||
| 943 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CHEMISTRY PANEL | Serum Chloride | 101 | 94 - 112 | mmol/L | ||||||||
| 944 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CREATININE CLEARANCE CC&G | CreatininClearancCockcrftGault | 1.33 | 1.25 - 1.92 | mL/sec | ||||||||
| 945 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CREATININE CLEARANCE CC&G | Creatinine(Rate Blanked)-2dp | 93 | 31 - 101 | umol/L | ||||||||
| 946 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | CREATININE CLEARANCE CC&G | Weight (kg,1dec place) | Y | 83.8 | kg | ||||||||
| 947 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | DRUG SCREEN URINE | Amphetamines/MDMA | Neg | Neg;$Cutoff = 1000 ng/mL | |||||||||
| 948 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | DRUG SCREEN URINE | Barbiturates | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 949 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | DRUG SCREEN URINE | Cannabinoids | Neg | Neg;$Cutoff = 50 ng/mL | |||||||||
| 950 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | DRUG SCREEN URINE | Cocaine | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 951 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | DRUG SCREEN URINE | Opiates | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 952 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | DRUG SCREEN URINE | Methadone | Neg | Neg;$Cutoff = 300 ng/mL | |||||||||
| 953 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | DRUG SCREEN URINE BENZO NON-US | Benzodiazepines Gen 2 | Neg | Neg;$Cutoff = 200 ng/mL | |||||||||
| 954 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | No | |||||||||
| 955 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | FSH | Follicle Stimulating Hormone | 32.96 | RX | Follicular:$3.90-8.80 IU/L$Midcycle:$4.50-22.50 IU/L$Luteal:$1.80-5.10 IU/L$Postmenopausal:$16.70-113.60 IU/L | ||||||||
| 956 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | GFR | EGFR by MDRD | 54 | mL/min/1.73m^2$No Ref Rng | |||||||||
| 957 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 117 | 116 - 164 | g/L | ||||||||
| 958 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.35 | 0.34 - 0.48 | |||||||||
| 959 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.3 | 4.1 - 5.6 | TI/L | ||||||||
| 960 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||
| 961 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 81 | 79 - 98 | fL | ||||||||
| 962 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 5.93 | 3.8 - 10.7 | GI/L | ||||||||
| 963 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.05 | 1.96 - 7.23 | GI/L | ||||||||
| 964 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.14 | 0.91 - 4.28 | GI/L | ||||||||
| 965 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.46 | 0.12 - 0.92 | GI/L | ||||||||
| 966 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.25 | 0 - 0.57 | GI/L | ||||||||
| 967 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | 0 - 0.2 | GI/L | ||||||||
| 968 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 68.3 | 40.5 - 75 | % | ||||||||
| 969 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 19.2 | 15.4 - 48.5 | % | ||||||||
| 970 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.8 | 2.6 - 10.1 | % | ||||||||
| 971 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 4.2 | 0 - 6.8 | % | ||||||||
| 972 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.5 | 0 - 2 | % | ||||||||
| 973 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 157 | 140 - 400 | GI/L | ||||||||
| 974 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | HEMOGLOBIN A1C | Hemoglobin A1c,Variant(-70)-QT | 6.5 | H | <6.5% | ||||||||
| 975 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | INSULIN | Ultra.Insulin,EDTApl,FastingQT | 27.42 | H | 1.9 - 23 | uIU/mL | |||||||
| 976 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||
| 977 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | IS SUBJECT OF BLACK RACE? | Subject of black race? | Y | No | |||||||||
| 978 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | LIPID PANEL | Direct HDL-C 4th Generation | 0.82 | R | L | 1.03 - 1.53 | mmol/L | ||||||
| 979 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | LIPID PANEL | Triglycerides (GPO) | 2.78 | 0.59 - 2.96 | mmol/L | ||||||||
| 980 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | LIPID PANEL | Cholesterol (High Performance) | 5.73 | 4.42 - 7.53 | mmol/L | ||||||||
| 981 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | LIPID PANEL | LDL Chol Friedewald 4th | 3.64 | H | 0 - 3.34 | mmol/L | |||||||
| 982 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | POSTMENOPAUSAL FEMALE? | <40yrs & amenorrhea >/= 12mo | Yes | ||||||||||
| 983 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | RETICULOCYTES | Reticulocyte Count % | 1.4 | 0.6 - 2.5 | % | ||||||||
| 984 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | TSH | TSH 3rd IS-QT | 1.091 | 0.45 - 5.33 | mIU/L | ||||||||
| 985 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | URINE MACRO PANEL | Ur Specific Gravity | 1.019 | 1 - 1.04 | |||||||||
| 986 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | URINE MACRO PANEL | Ur pH | 6.0 | 5 - 8 | |||||||||
| 987 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | URINE MACRO PANEL | Ur Protein | Negative | Ref Rng:Negative | |||||||||
| 988 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | URINE MACRO PANEL | Ur Glucose | Normal | Ref Rng:Normal | |||||||||
| 989 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | URINE MACRO PANEL | Ur Ketones | Negative | Ref Rng:Negative | |||||||||
| 990 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | URINE MACRO PANEL | Ur Bilirubin | Negative | Ref Rng:Negative | |||||||||
| 991 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | URINE MACRO PANEL | Ur Urobilinogen | Normal | Ref Rng:Normal | |||||||||
| 992 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | URINE MACRO PANEL | Ur Blood | Negative | Ref Rng:$Negative-Trace | |||||||||
| 993 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | URINE MACRO PANEL | Ur Nitrite | Negative | Ref Rng:Negative | |||||||||
| 994 | CZ100120001 | 56 | years | Female | Part 1 Screening | Aug 6, 2025 1:35 PM | 6225351106 | URINE MACRO PANEL | Ur Leukocyte Esterase | Negative | Ref Rng:Negative |